A Blood-based Metabolite Signature for Personalized Risk Assessment of Pancreatic Cancer

dc.contributor.authorLeón-Letelier, Ricardo A.
dc.contributor.authorChen, Yihui
dc.contributor.authorBallaro, Riccardo
dc.contributor.authorIrajizad, Ehsan
dc.contributor.authorDo, Kim-An
dc.contributor.authorMaitra, Anirban
dc.contributor.authorZhang, Jianjun
dc.contributor.authorSchmidt, C. Max
dc.contributor.authorFahrmann, Johannes F.
dc.contributor.departmentSurgery, School of Medicine
dc.date.accessioned2025-02-25T09:34:21Z
dc.date.available2025-02-25T09:34:21Z
dc.date.issued2024
dc.eprint.versionAuthor's manuscript
dc.identifier.citationLeón-Letelier RA, Chen Y, Ballaro R, et al. A Blood-based Metabolite Signature for Personalized Risk Assessment of Pancreatic Cancer. J Cancer Immunol (Wilmington). 2024;6(4):148-153. doi:10.33696/cancerimmunol.6.095
dc.identifier.urihttps://hdl.handle.net/1805/45991
dc.language.isoen_US
dc.publisherScientific Archives
dc.relation.isversionof10.33696/cancerimmunol.6.095
dc.relation.journalJournal of Cancer Immunology
dc.rightsPublisher Policy
dc.sourcePMC
dc.subjectPancreatic ductal adenocarcinoma (PDAC)
dc.subjectCancer-related deaths
dc.subjectLocalized disease
dc.subjectMetastatic
dc.titleA Blood-based Metabolite Signature for Personalized Risk Assessment of Pancreatic Cancer
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
LeónLetelier2024Blood-AAM.pdf
Size:
489.65 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description: